135 related articles for article (PubMed ID: 6279014)
1. The activity of five cephalosporins against Bacteroides fragilis.
Ryan RW; Kwasnik I; Tilton RC
Ann Clin Lab Sci; 1982; 12(1):32-4. PubMed ID: 6279014
[No Abstract] [Full Text] [Related]
2. Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
Fu KP; Neu HC
J Antimicrob Chemother; 1981 Oct; 8(4):337-41. PubMed ID: 6271727
[No Abstract] [Full Text] [Related]
3. In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
Lang SD; Durack DT
Clin Ther; 1980; 3(Spec Issue):112-6. PubMed ID: 6248219
[No Abstract] [Full Text] [Related]
4. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Brown JE; Del Bene VE; Collins CD
Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
Owens WE; Finegold SM
Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
[TBL] [Abstract][Full Text] [Related]
7. Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
Antimicrob Agents Chemother; 1984 Jan; 25(1):131-3. PubMed ID: 6322676
[TBL] [Abstract][Full Text] [Related]
8. [Moxalactam: preclinical evaluation].
Chabbert YA
Sem Hop; 1983 Jun; 59(26):1943-6. PubMed ID: 6310782
[No Abstract] [Full Text] [Related]
9. The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
Ahonkhai VI; Sierra MF; Cherubin CE; Shulman MA
J Antimicrob Chemother; 1982 May; 9(5):411-2. PubMed ID: 6284696
[No Abstract] [Full Text] [Related]
10. In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Nasu M; Maskell JP; Williams RJ; Williams JD
Antimicrob Agents Chemother; 1981 Oct; 20(4):433-6. PubMed ID: 6282191
[TBL] [Abstract][Full Text] [Related]
11. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Fuchs PC; Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
[TBL] [Abstract][Full Text] [Related]
12. The in vitro responses of Bacteroides fragilis to Moxalactam, Cefotaxime, Cefmetazole, Josamycin and erythromycin.
Soriano F; Ponte MC; Gaspar MC
J Clin Pathol; 1982 Oct; 35(10):1166-7. PubMed ID: 6290543
[No Abstract] [Full Text] [Related]
13. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Baumgärtner M; Grehn M; Wundt W
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
[TBL] [Abstract][Full Text] [Related]
14. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.
Aldridge KE; Gelfand M; Reller LB; Ayers LW; Pierson CL; Schoenknecht F; Tilton RC; Wilkins J; Henderberg A; Schiro DD
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):235-41. PubMed ID: 7924220
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins.
Chow AW; Finegold SM
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():45-50. PubMed ID: 6296028
[No Abstract] [Full Text] [Related]
16. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
Kawakami Y; Okimura Y; Horiuchi N; Kanai M
Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
[No Abstract] [Full Text] [Related]
17. Enzyme-mediated resistance of Bacteroides fragilis to moxalactam.
Maskell JP; Nasu M
Lancet; 1981 Mar; 1(8222):733. PubMed ID: 6110951
[No Abstract] [Full Text] [Related]
18. [In vitro activity of the oxa-beta-lactam LY 127935 against Bacteroides fragilis and other anaerobic gram-negative rods (author's transl)].
Werner H; Krasemann C
Infection; 1980; 8 Suppl 3():S 342-6. PubMed ID: 6447673
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
Kays MB; White RL; Friedrich LV; Del Bene VE
Clin Ther; 1991; 13(5):596-605. PubMed ID: 1799917
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
Greenfield RA; Kurzynski TA; Craig WA
Antimicrob Agents Chemother; 1982 May; 21(5):846-7. PubMed ID: 6285817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
